Summary
Drugs have been widely associated with the development of delirium in the elderly and represent the most common reversible cause of this condition. This is of importance since successful treatment depends on identifying the reversible contributing factors. Medications with anticholinergic properties, tranquilizers, analgesics and narcotics are common causes of drug-induced delirium. This article provides practical approach to prevent and recognise this condition, reviews the underlying neurotransmitter imbalances and reconsiders age-related changes of pharmacological effects, which may contribute to the development of delirium.
Zusammenfassung
Medikamente sind häufige Auslöser von Delirien älterer Menschen und stellen dabei die häufigste reversible Ursache dar – dies ist von besonderer Bedeutung, da die Identifikation auslösender Faktoren die Grundlage einer erfolgreichen Therapie darstellt. Anticholinerg wirksame Medikamente, Tranquilizer, Schmerzmittel und Narkotika sind geläufige Auslöser von Delirien. Dieser Artikel bietet eine klinisch orientierte Übersicht über Prävention und Diagnose pharmakogener Delirien. Neben altersassoziierten Veränderungen der Pharmakologie werden die zu Grunde liegenden pathophysiologischen Mechanismen vor dem Hintergrund der involvierten Neurotransmitter dargestellt.
Similar content being viewed by others
Literatur
American Psychiatric Assiciation WD. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. APA. 1994
Gaudreau JD, Gagnon P, Roy MA, Harel F, Tremblay A. Association between psychoactive medications and delirium in hospitalized patients: a critical review. Psychosomatics, 46(4): 302–316, 2005
Alagiakrishnan K, Wiens CA. An approach to drug induced delirium in the elderly. Postgrad Med J, 80(945): 388–393, 2004
O'Keeffe ST, Lavan JN. Clinical significance of delirium subtypes in older people. Age Ageing, 28(2): 115–119, 1999
Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing, 35(4): 350–364, 2006
Inouye SK, Schlesinger MJ, Lydon TJ. Delirium: a symptom of how hospital care is failing older persons and a window to improve quality of hospital care. Am J Med, 106(5): 565–573, 1999
Young J, Inouye SK. Delirium in older people. BMJ, 334(7598): 842–846, 2007
Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med, 113(12): 941–948, 1990
Inouye SK. Delirium in older persons. N Engl J Med, 354(11): 1157–1165, 2006
Flacker JM, Cummings V, Mach JR Jr., Bettin K, Kiely DK, Wei J. The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatry, 6(1): 31–41, 1998
Hshieh TT, Fong TG, Marcantonio ER, Inouye SK. Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci, 63(7): 764–772, 2008
Itil T, Fink M. Anticholinergic drug-induced delirium: experimental modification, quantitative EEG and behavioral correlations. J Nerv Ment Dis, 143(6): 492–507, 1966
Nagasawa H, Araki T, Kogure K. Alteration of muscarinic acetylcholine binding sites in the postischemic brain areas of the rat using in?vitro autoradiography. J Neurol Sci, 121(1): 27–31, 1994
Trzepacz PT. Update on the neuropathogenesis of delirium. Dement Geriatr Cogn Disord, 10(5): 330–334, 1999
Jaber M, Robinson SW, Missale C, Caron MG. Dopamine receptors and brain function. Neuropharmacology, 35(11): 1503–1519, 1996
Rudorfer MV, Manji HK, Potter WZ. Bupropion, ECT, and dopaminergic overdrive. Am J Psychiatry, 148(8): 1101–1102, 1991
Wetli CV, Mash D, Karch SB. Cocaine-associated agitated delirium and the neuroleptic malignant syndrome. Am J Emerg Med, 14(4): 425–428, 1996
Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med, 352(11): 1112–1120, 2005
Levin TT, Cortes-Ladino A, Weiss M, Palomba ML. Life-threatening serotonin toxicity due to a citalopram-fluconazole drug interaction: case reports and discussion. Gen Hosp Psychiatry, 30(4): 372–377, 2008
Kiangkitiwan B, Doppalapudi A, Fonder M, Solberg K, Bohner B. Levofloxacin-induced delirium with psychotic features. Gen Hosp Psychiatry, 30(4): 381–383, 2008
Hopkins MH, Silverman RB. Beta-lactams: a new class of conformationally-rigid inhibitors of gamma-aminobutyric acid aminotransferase. J Enzyme Inhib, 6(2): 125–129, 1992
Campbell KM, Schubert DS. Delirium after cessation of glucocorticoid therapy. Gen Hosp Psychiatry, 13(4): 270–272, 1991
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iglseder, B., Dovjak, P., Benvenuti-Falger, U. et al. Medikamenten-induzierte Delirien älterer Menschen. Wien Med Wochenschr 160, 281–285 (2010). https://doi.org/10.1007/s10354-010-0787-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10354-010-0787-0